Industry / Hungary
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Pfizer Looking To Build New R&D Facility In CEE
August 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
US pharmaceutical giant Pfizer is looking to build a new R&D centre in Central and Eastern Europe (CEE), with Hungary one of the key contenders. According to the head of Pfizer's Hungarian subsidiary, Mario Gattino, the company has already secured a grant from the Hungarian government if it decides to build the facility in the country, and a decision will be made sometime in late